^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    XZP-KM257

    i
    Other names: XZP-KM257, KM257, HER2/HER2 bispecific antibody
    Associations

    News

    Trials
    Company:
    Sihuan Pharmaceutical
    Drug class:
    HER2 antagonist
    Related drugs:
    Associations

    News

    Trials
    2years
    A Study of KM257 in Patients With Advanced HER2-positive or Expressing Solid Tumors. (clinicaltrials.gov)
    P1, N=232, Not yet recruiting, Xuanzhu Biopharmaceutical Co., Ltd.
    New P1 trial
    |
    HER-2 (Human epidermal growth factor receptor 2) • KRAS (KRAS proto-oncogene GTPase) • BRAF (B-raf proto-oncogene) • NRAS (Neuroblastoma RAS viral oncogene homolog)
    |
    HER-2 positive • BRAF V600E • KRAS mutation • NRAS mutation • BRAF V600 • HER-2 expression
    |
    cisplatin • carboplatin • paclitaxel • docetaxel • capecitabine • irinotecan • XZP-KM257